Becton, Dickinson and Company (BDX): $246.71

-0.99 (-0.40%)

POWR Rating

Component Grades













Becton Dickinson & Co (BDX) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering BDX.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
14 $300 $260 $281.57 $247.7 13.67%

The Trend in the Analyst Price Target

BDX's average price target has moved down $10.5 over the prior 148 days.

BDX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.53 5 6 6 0 0 17

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • BDX has a greater average analyst price target than 96.24% of all US stocks.
  • BDX has a lower variance in analysts' estimates than 94.28% of stocks in the large market cap category.
  • BDX has a greater number of analysts covering the stock than 90.59% of Medical Equipment stocks.
  • Becton Dickinson & Co's upside potential (average analyst target price relative to current price) is higher than 29.66% of Healthcare stocks.
  • Becton Dickinson & Co's NA is greater than practically none of all US stocks.

Stocks similar to Becton Dickinson & Co in the Medical Equipment industry regarding analyst recommendations and price targets are COO, BAX and TNDM.

Is BDX a Buy, Hold or Sell? See the POWR Ratings now!

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8575 seconds.